Compare WGS & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | NEOG |
|---|---|---|
| Founded | 2017 | 1981 |
| Country | United States | United States |
| Employees | N/A | 1257 |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.7B |
| IPO Year | 2020 | 1995 |
| Metric | WGS | NEOG |
|---|---|---|
| Price | $58.18 | $12.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $93.50 | $14.00 |
| AVG Volume (30 Days) | 643.6K | ★ 4.2M |
| Earning Date | 11-03-2026 | 10-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 62.37 | ★ 99.20 |
| EPS | N/A | ★ N/A |
| Revenue | $427,539,000.00 | ★ $870,400,000.00 |
| Revenue This Year | $12.70 | $1.73 |
| Revenue Next Year | $24.31 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 39.97 | N/A |
| 52 Week Low | $32.21 | $5.37 |
| 52 Week High | $170.87 | $14.26 |
| Indicator | WGS | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 32.45 | 51.47 |
| Support Level | $56.36 | $11.25 |
| Resistance Level | $73.04 | $12.52 |
| Average True Range (ATR) | 5.31 | 0.64 |
| MACD | -0.35 | -0.02 |
| Stochastic Oscillator | 8.86 | 52.79 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.